Literature DB >> 22464969

Control of pandemic (H1N1) 2009 influenza virus infection of ferret lungs by non-adjuvant-containing pandemic and seasonal vaccines.

Steven Rockman1, Deborah J Middleton, Martin J Pearse, Ian G Barr, Sue Lowther, Lorena E Brown.   

Abstract

The pandemic H1N1 2009 influenza virus caused relatively mild disease in most infected people but some suffered extensively from primary lung infection, many more than would have occurred with seasonal influenza infection. Early commercially available pandemic H1N1 vaccines did not contain adjuvant, as did many of the subsequent vaccines, and could not stop infection with the pandemic virus in vaccinated ferrets. Nevertheless, we showed that virus loads in the lungs were greatly diminished in ferrets vaccinated once with an unadjuvanted pandemic vaccine and challenged with 10(6)EID(50) wildtype A/California/07/2009 (H1N1). In addition, a single inoculation with seasonal vaccine showed beneficial reduction in pandemic pulmonary virus loads in the absence of any detectable cross-reactive serological responses. Ferrets primed with either seasonal or pandemic vaccine and then boosted with pandemic vaccine also showed less extensive lung infection when challenged with a tenfold higher dose of pandemic virus. These results implicate non-classical protective mechanisms that prevent severe pulmonary disease but not viral shedding and imply that particular non-adjuvanted vaccines may have retained the ability to induce these responses.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22464969     DOI: 10.1016/j.vaccine.2012.03.043

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  8 in total

1.  Induction of Broad-Based Immunity and Protective Efficacy by Self-amplifying mRNA Vaccines Encoding Influenza Virus Hemagglutinin.

Authors:  Michela Brazzoli; Diletta Magini; Alessandra Bonci; Scilla Buccato; Cinzia Giovani; Roland Kratzer; Vanessa Zurli; Simona Mangiavacchi; Daniele Casini; Luis M Brito; Ennio De Gregorio; Peter W Mason; Jeffrey B Ulmer; Andrew J Geall; Sylvie Bertholet
Journal:  J Virol       Date:  2015-10-14       Impact factor: 5.103

2.  Intravenous Immunoglobulin Protects Against Severe Pandemic Influenza Infection.

Authors:  Steven Rockman; Sue Lowther; Sarina Camuglia; Kirsten Vandenberg; Shirley Taylor; Lou Fabri; Sylvia Miescher; Martin Pearse; Deborah Middleton; Stephen J Kent; Darryl Maher
Journal:  EBioMedicine       Date:  2017-04-06       Impact factor: 8.143

3.  Comparison of a novel microcrystalline tyrosine adjuvant with aluminium hydroxide for enhancing vaccination against seasonal influenza.

Authors:  M D Heath; N J Swan; A C Marriott; N J Silman; B Hallis; C Prevosto; K E Gooch; M A Skinner
Journal:  BMC Infect Dis       Date:  2017-03-27       Impact factor: 3.090

4.  TaqMan real time RT-PCR assays for detecting ferret innate and adaptive immune responses.

Authors:  Louise A Carolan; Jeff Butler; Steve Rockman; Teagan Guarnaccia; Aeron C Hurt; Patrick Reading; Anne Kelso; Ian Barr; Karen L Laurie
Journal:  J Virol Methods       Date:  2014-05-04       Impact factor: 2.014

5.  Antigenic drift of the pandemic 2009 A(H1N1) influenza virus in A ferret model.

Authors:  Teagan Guarnaccia; Louise A Carolan; Sebastian Maurer-Stroh; Raphael T C Lee; Emma Job; Patrick C Reading; Stephen Petrie; James M McCaw; Jodie McVernon; Aeron C Hurt; Anne Kelso; Jennifer Mosse; Ian G Barr; Karen L Laurie
Journal:  PLoS Pathog       Date:  2013-05-09       Impact factor: 6.823

6.  Transmission routes for nipah virus from Malaysia and Bangladesh.

Authors:  Bronwyn A Clayton; Deborah Middleton; Jemma Bergfeld; Jessica Haining; Rachel Arkinstall; Linfa Wang; Glenn A Marsh
Journal:  Emerg Infect Dis       Date:  2012-12       Impact factor: 6.883

7.  Randomized controlled ferret study to assess the direct impact of 2008-09 trivalent inactivated influenza vaccine on A(H1N1)pdm09 disease risk.

Authors:  Danuta M Skowronski; Marie-Eve Hamelin; Gaston De Serres; Naveed Z Janjua; Guiyun Li; Suzana Sabaiduc; Xavier Bouhy; Christian Couture; Anders Leung; Darwyn Kobasa; Carissa Embury-Hyatt; Erwin de Bruin; Robert Balshaw; Sophie Lavigne; Martin Petric; Marion Koopmans; Guy Boivin
Journal:  PLoS One       Date:  2014-01-27       Impact factor: 3.240

8.  Altered microRNA expression in COVID-19 patients enables identification of SARS-CoV-2 infection.

Authors:  Ryan J Farr; Christina L Rootes; Louise C Rowntree; Thi H O Nguyen; Luca Hensen; Lukasz Kedzierski; Allen C Cheng; Katherine Kedzierska; Gough G Au; Glenn A Marsh; Seshadri S Vasan; Chwan Hong Foo; Christopher Cowled; Cameron R Stewart
Journal:  PLoS Pathog       Date:  2021-07-28       Impact factor: 6.823

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.